Alternatives to Nectin Therapeutics

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

AI-powered blood test for early cancer detection and subtyping.

Omnix Medical is developing a novel platform for advanced wound care management.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.